CoChat

Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

McColl, SL, Burstein, AH, Reeves, KR, Billing Jr, CB, Stolar, M, Sellers, EM · 2008 · Clinical Pharmacology & Therapeutics
Cited by 40

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Varenicline is an alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist developed as an aid for smoking cessation. This study evaluated varenicline's potential for abuse by smokers (n = 23) and nonsmokers (n = 22). The study used a randomized, double-blind, placebo-controlled, double-dummy crossover design with five treatment periods: 15 and 30 mg amphetamine, 1 and 3 mg varenicline, and placebo. Following each treatment, the participants were assessed on aspects relating to potential abuse of the drug (e.g., drug liking, drug high, and drug monetary value). The positive effects measured for 3 mg varenicline were similar to those for the placebo, and significantly lower than those for amphetamine in both smokers and nonsmokers. Unpleasant effects were reported for 3 mg varenicline in both participant groups. For 1 mg varenicline, the overall patterns were similar, with the exception that the nonsmokers group showed some small positive effects balanced by some negative effects when compared with the effects of placebo. These findings lead to the conclusion that varenicline is unlikely to be abused.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.clpt.6100510

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 40

Metadata

Authors
McColl, S., Burstein, A., Reeves, K., Billing Jr, C., Stolar, M., & Sellers, E.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2008-02-20
Volume
83
Issue
4
Pages
607-614
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2090321716
Cited by
40
References
12
FWCI
4.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers. https://app.cochat.ai/papers/10.1038/sj.clpt.6100510
The paper
McColl, S., Burstein, A., Reeves, K., Billing Jr, C., Stolar, M., & Sellers, E. (2008). Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/sj.clpt.6100510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.